All lobbying filings
BELL & LINDSAY, INC.
Lobbying for METABOLIC SYNDROME INSULIN INFUSION HOLDINGS LLC · treatment of metabolic disorders, including diabetes.
Filing
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$15,000.00
What the client paid this registrant for the period.
Client based in
Virginia
Lobbyists on this filing
1
-
MARK F LINDSAYPreviously held: U.S House Staff
Government bodies contacted
3
Lobbying activity
2
education around MSII's value proposition to treat metabolic health disorders.
education around MSII's value proposition to treat metabolic health disorders.